Melinta therapeutics, inc. /new/ (MLNT)
Balance Sheet / TTM
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11
Assets
Current assets
Cash and Cash Equivalents, at Carrying Value

63,521

90,343

116,901

81,808

83,795

150,087

91,479

128,387

176,134

187,005

202,763

11,409

248,917

250,744

223,609

153,765

182,017

202,407

209,118

99,113

74,172

68,642

79,554

96,502

110,403

121,631

60,151

70,108

51,642

57,847

65,910

15,602

Receivables (See Note 3)

18,933

19,081

14,892

22,485

8,073

8,064

11,271

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other receivables

-

-

-

-

30,831

12,546

11,619

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Receivables (See Note 3)

-

-

-

-

-

-

-

7,564

-

-

-

454

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory (See Note 3)

39,275

42,043

44,451

41,341

36,028

33,960

28,220

10,825

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

9,538

5,292

5,512

3,848

6,343

5,510

7,322

2,988

-

-

-

3,226

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Receivables

-

-

-

-

-

-

-

-

2,803

2,413

6,339

-

4,531

4,031

3,846

7,639

3,097

3,694

14,217

2,350

3,588

1,335

3,145

1,626

974

232

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

833

1,014

1,228

-

792

1,323

1,241

573

1,376

1,791

2,518

3,387

3,721

2,964

1,769

407

324

512

643

264

160

596

955

284

Deferred offering expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

880

Total current assets

131,267

156,759

181,756

149,482

165,070

210,167

149,911

149,764

179,770

190,432

210,330

15,089

254,240

256,098

228,696

161,977

186,490

207,893

225,854

104,851

81,482

72,942

84,469

98,537

111,702

122,376

60,795

70,373

51,803

58,443

66,865

16,767

Property and equipment, net

1,168

1,309

1,465

1,586

2,312

2,459

2,276

1,596

27

33

39

1,101

59

69

75

90

104

119

140

113

129

144

144

137

72

71

56

43

48

53

68

81

In-process research and development

-

-

-

-

19,859

19,859

20,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible assets, net

40,100

220,949

225,073

229,196

217,616

221,877

240,825

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

-

-

-

-

17,757

17,614

13,059

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible assets, net

-

-

-

-

-

-

-

7,500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other Assets, Noncurrent

55,956

61,355

62,155

61,326

59,688

42,671

22,678

1,413

-

-

-

444

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deposits

-

-

-

-

-

-

-

-

83

83

129

-

146

218

152

73

57

57

346

346

346

381

345

333

322

322

321

321

321

9

9

9

Total assets

228,491

440,372

470,449

441,590

482,302

514,647

448,749

160,273

179,880

190,548

210,498

16,634

254,445

256,385

228,923

162,140

186,653

208,070

226,341

105,310

81,958

73,468

84,959

99,007

112,097

122,770

61,173

70,738

52,173

58,506

66,944

16,858

Liabilities
Current liabilities
Accounts payable

8,920

5,792

8,321

16,765

16,262

13,352

12,463

7,405

6,665

6,752

11,783

5,136

12,531

14,534

11,192

9,635

14,918

13,753

10,851

11,893

10,761

9,402

8,786

6,273

3,888

1,973

1,608

2,171

1,326

2,450

2,650

2,980

Accrued Liabilities, Current

25,483

27,260

22,625

33,924

25,788

31,386

29,437

24,041

1,036

1,408

4,620

6,360

2,090

1,232

993

1,475

1,470

776

524

1,002

822

404

462

391

422

879

998

341

235

1,218

721

545

Deferred Purchase Price And Contingent Consideration Current

83,173

83,031

82,316

78,394

46,103

23,925

22,830

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent milestone payments

-

-

-

-

28,500

27,052

27,184

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Notes payable, net

-

-

-

-

-

-

-

-

-

-

-

11,075

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest on notes payable

-

4,305

4,440

-

4,389

4,389

-

284

-

-

-

174

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liability

15

129

23

38

2,617

6,790

9,179

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion liability (See Note 4)

5,894

11,869

12,236

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued payroll and benefits

-

-

-

-

-

-

-

-

1,286

986

627

-

3,679

2,226

1,051

2,337

1,955

1,230

564

1,595

1,293

857

413

1,043

714

466

211

604

502

372

186

421

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

533

31

31

31

22

22

-

-

-

-

-

-

Preferred stock warrants

-

-

-

-

-

-

-

-

-

-

-

674

-

-

-

-

-

-

-

-

-

-

875

920

821

690

-

-

-

-

-

1,120

Current portion of long-term debt

-

-

-

-

-

-

-

-

6,667

6,667

6,667

-

6,667

6,667

6,111

4,444

2,777

6,036

5,021

3,593

1,799

443

0

2,200

1,085

-

3,008

2,226

1,464

723

-

-

Total current liabilities

128,047

132,386

129,961

133,606

123,659

106,894

101,093

31,730

15,654

15,813

23,697

23,419

24,967

24,659

19,347

17,891

21,122

21,797

16,961

18,085

15,210

11,139

10,570

10,861

6,955

4,033

5,827

5,344

3,529

4,765

3,559

5,068

Long-term liabilities
Notes Payable, Noncurrent

89,076

93,821

91,397

110,476

108,976

107,463

106,090

39,555

-

-

-

12,647

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

0

-

-

10,008

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent consideration

-

-

-

-

12,626

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible notes payable to related parties, net of debt discount and costs (See note 4)

63,716

63,239

62,350

0

-

-

-

-

-

-

-

45,127

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenues

-

-

-

-

-

-

-

-

16,987

16,987

16,987

9,008

11,326

11,326

11,326

11,326

11,325

11,325

11,325

11,325

11,329

5,632

5,632

5,632

5,641

5,641

-

-

-

-

-

-

Deferred purchase price and contingent consideration

-

-

-

-

-

31,289

33,393

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued notes payable exit fee

-

-

-

-

-

-

-

-

-

-

-

1,050

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other Liabilities, Noncurrent

8,183

9,259

10,225

7,444

2,261

8,027

8,340

6,644

-

-

-

491

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total long-term liabilities

160,975

166,319

163,972

117,920

123,863

146,779

147,823

56,207

-

-

-

68,323

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term debt

-

-

-

-

-

-

-

-

3,682

5,342

7,002

-

10,300

11,953

13,606

15,258

16,929

12,362

13,634

14,878

16,478

17,663

14,923

12,538

-

-

-

7,623

8,297

8,951

9,589

-

Convertible notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,457

Long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,435

14,283

6,929

-

-

-

-

9,503

Total liabilities

289,022

298,705

293,933

251,526

247,522

253,673

248,916

87,937

36,323

38,142

47,686

91,742

46,593

47,938

44,279

44,475

49,378

45,486

41,922

44,289

43,018

34,435

31,126

29,032

26,032

23,958

12,757

12,967

11,827

13,717

13,148

19,029

Commitments and contingencies (See Note 10)

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

Total convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

218,343

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

94,514

Shareholders' Equity
Preferred stock; $.001 par value; 5,000,000 shares authorized; -0- shares issued or outstanding at September 30, 2019, and December 31, 2018, respectively

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

0

-

-

-

-

Common stock; $.001 par value; 80,000,000 shares authorized; 13,750,691 and 11,204,050 issued and outstanding at September 30, 2019, and December 31, 2018, respectively

14

12

12

11

56

56

31

4

53

53

52

-

52

51

48

44

43

43

43

37

34

33

33

33

33

33

24

24

21

21

21

-

Additional paid-in capital

-

-

-

-

-

-

-

-

626,001

624,491

622,631

-

613,345

581,629

533,024

436,643

435,096

432,835

429,701

288,892

-

-

-

236,202

-

-

-

-

-

-

-

-

Additional paid-in capital

937,334

926,152

924,821

909,896

910,447

908,781

791,885

644,991

-

-

-

220,292

-

-

-

-

-

-

-

-

249,919

238,658

237,081

-

235,462

234,562

179,961

178,970

154,982

154,445

153,923

-

Retained Earnings (Accumulated Deficit)

-997,879

-784,497

-748,317

-719,843

-675,723

-647,863

-592,083

-572,659

-482,497

-472,138

-459,871

-513,743

-405,545

-373,233

-348,428

-319,022

-297,865

-270,295

-245,325

-227,909

-211,014

-199,658

-183,281

-166,260

-

-

-

-121,225

-

-

-

-

Deficit accumulated during the development stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-149,430

-135,783

-131,570

-

-114,657

-109,676

-100,148

-96,685

Stockholders' Equity Attributable to Parent

-60,531

141,667

176,516

190,064

234,780

260,974

199,833

72,336

143,557

152,406

162,812

-293,451

207,852

208,447

184,644

117,665

137,275

162,584

184,418

61,020

38,939

39,032

53,833

69,975

86,064

98,811

48,416

57,770

40,346

44,789

53,796

-96,685

Total liabilities and shareholders’ equity

228,491

440,372

470,449

441,590

482,302

514,647

448,749

160,273

179,880

190,548

210,498

16,634

254,445

256,385

228,923

162,140

186,653

208,070

226,341

105,310

81,958

73,468

84,959

99,007

112,097

122,770

61,173

70,738

52,173

58,506

66,944

16,858

Notes Payable
Accrued interest on notes payable

4,046

-

-

4,485

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible Subordinated Debt
Accrued interest on notes payable

516

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-